VX-222 is a novel, potent and selective inhibitor of non-nucleoside polymerase of the hepatitis C virus (HCV) RNA-dependent RNA polymerase, with an IC50 range of 0.94-1.2 µM. VX-222 selectively inhibits the replication of both HCV1a and HCV1b.
Synonym(s): VCH-222 Purity:≥98%
Solubility: ≥50 mg/ml in DMSO Format: White crystalline powder Storage / Stability: Store at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day. Scientific Category: Protease Product Type: Inhibitor Data shown is lot-specific. Contact us for specific information on other lots.